Could a diabetes drug help fight head and neck cancer? new study tests combo therapy
NCT ID NCT04414540
First seen Jan 04, 2026 · Last updated Jun 17, 2026 · Updated 21 times
Summary
This study tested whether combining the immunotherapy drug pembrolizumab with the diabetes drug metformin could help shrink tumors in people with advanced head and neck cancer that has spread. The trial enrolled 21 adults whose cancer could not be cured with surgery or radiation. The goal was to see how many patients responded to the treatment and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45219, United States
Conditions
Explore the condition pages connected to this study.